Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Clinical trial NCT06790290 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06790290
Sponsor: Inventprise Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pneumococcal Disease, Invasive

Start date: 2025-01-27
Primary completion: 2025-04-03
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.